Vitality Biopharma, Inc. announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced operating loss was USD 466,542 compared to USD 748,766 a year ago. Net income was USD 692,950 compared to net loss of USD 795,295 a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the nine months, operating loss was USD 1.680 million compared to USD 2.958 million a year ago. Net loss was USD 520,220 compared to USD 3.614 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.06 a year ago.